SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOPAMINE AGONIST LISURIDE
作者:
P. G. CHIODINI,
A. LIUZZI,
G. VERDE,
R. COZZI,
F. SILVESTRINI,
M. T. MARSILI,
R. HOROWSKI,
F. PASSERINI,
G. LUCCARELLI,
P. G. BORGHI,
期刊:
Clinical Endocrinology
(WILEY Available online 1980)
卷期:
Volume 12,
issue 1
页码: 47-51
ISSN:0300-0664
年代: 1980
DOI:10.1111/j.1365-2265.1980.tb03131.x
出版商: Blackwell Publishing Ltd
数据来源: WILEY
摘要:
SUMMARYA 38–year‐old amenorrhoeic woman suffering from a prolactin (PRL) secreting adenoma, which had suprasellar extension as shown by carotid angiography and computed axial tomography (CAT), was treated with a dopamine agonist (lisuride). PRL levels were lowered and after 1 year of treatment CAT showed a marked reduction of the tumour size. After 2 years of treatment menstruation returned and CAT demonstrated a further reduction of the adenomatous tissue. This study supports the suggestion that dopamine agonists possess an anti‐pro‐liferative effect on tumoural lactotrophic cells of
点击下载:
PDF
(877KB)
返 回